Yu, J.I.; Park, H.C.; Yoo, G.S.; Paik, S.W.; Choi, M.S.; Kim, H.-S.; Sohn, I.; Nam, H.
Clinical Significance of Systemic Inflammation Markers in Newly Diagnosed, Previously Untreated Hepatocellular Carcinoma. Cancers 2020, 12, 1300.
https://doi.org/10.3390/cancers12051300
AMA Style
Yu JI, Park HC, Yoo GS, Paik SW, Choi MS, Kim H-S, Sohn I, Nam H.
Clinical Significance of Systemic Inflammation Markers in Newly Diagnosed, Previously Untreated Hepatocellular Carcinoma. Cancers. 2020; 12(5):1300.
https://doi.org/10.3390/cancers12051300
Chicago/Turabian Style
Yu, Jeong Il, Hee Chul Park, Gyu Sang Yoo, Seung Woon Paik, Moon Seok Choi, Hye-Seung Kim, Insuk Sohn, and Heerim Nam.
2020. "Clinical Significance of Systemic Inflammation Markers in Newly Diagnosed, Previously Untreated Hepatocellular Carcinoma" Cancers 12, no. 5: 1300.
https://doi.org/10.3390/cancers12051300
APA Style
Yu, J. I., Park, H. C., Yoo, G. S., Paik, S. W., Choi, M. S., Kim, H.-S., Sohn, I., & Nam, H.
(2020). Clinical Significance of Systemic Inflammation Markers in Newly Diagnosed, Previously Untreated Hepatocellular Carcinoma. Cancers, 12(5), 1300.
https://doi.org/10.3390/cancers12051300